Annual Revenue
$84.82 M
+$19.55 M+29.96%
31 December 2023
Summary:
Y-mAbs Therapeutics annual revenue is currently $84.82 million, with the most recent change of +$19.55 million (+29.96%) on 31 December 2023. During the last 3 years, it has risen by +$64.07 million (+308.77%). YMAB annual revenue is now at all-time high.YMAB Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$18.46 M
-$4.34 M-19.02%
30 September 2024
Summary:
Y-mAbs Therapeutics quarterly revenue is currently $18.46 million, with the most recent change of -$4.34 million (-19.02%) on 30 September 2024. Over the past year, it has dropped by -$1.99 million (-9.74%). YMAB quarterly revenue is now -41.29% below its all-time high of $31.45 million, reached on 31 December 2022.YMAB Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$84.55 M
-$1.99 M-2.30%
30 September 2024
Summary:
Y-mAbs Therapeutics TTM revenue is currently $84.55 million, with the most recent change of -$1.99 million (-2.30%) on 30 September 2024. Over the past year, it has dropped by -$8.35 million (-8.99%). YMAB TTM revenue is now -8.99% below its all-time high of $92.90 million, reached on 30 September 2023.YMAB TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMAB Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +30.0% | -9.7% | -9.0% |
| 3 y3 years | +308.8% | +105.9% | +83.6% |
| 5 y5 years | - | - | - |
YMAB Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +308.8% | -41.3% | +105.9% | -9.0% | +142.3% |
| 5 y | 5 years | at high | +308.8% | -41.3% | +242.9% | -9.0% | +307.5% |
| alltime | all time | at high | +308.8% | -41.3% | +242.9% | -9.0% | +307.5% |
Y-mAbs Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $18.46 M(-19.0%) | $84.55 M(-2.3%) |
| June 2024 | - | $22.80 M(+14.4%) | $86.55 M(+2.4%) |
| Mar 2024 | - | $19.93 M(-14.7%) | $84.50 M(-0.4%) |
| Dec 2023 | $84.82 M(+30.0%) | $23.36 M(+14.2%) | $84.82 M(-8.7%) |
| Sept 2023 | - | $20.45 M(-1.4%) | $92.90 M(+9.3%) |
| June 2023 | - | $20.75 M(+2.5%) | $84.99 M(+13.3%) |
| Mar 2023 | - | $20.25 M(-35.6%) | $75.03 M(+15.0%) |
| Dec 2022 | $65.27 M | $31.45 M(+150.8%) | $65.27 M(+50.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | $12.54 M(+16.1%) | $43.42 M(+9.0%) |
| June 2022 | - | $10.80 M(+3.0%) | $39.85 M(-0.4%) |
| Mar 2022 | - | $10.49 M(+9.3%) | $40.00 M(+14.6%) |
| Dec 2021 | $34.90 M(+68.2%) | $9.60 M(+7.1%) | $34.90 M(-24.2%) |
| Sept 2021 | - | $8.96 M(-18.1%) | $46.05 M(+24.2%) |
| June 2021 | - | $10.95 M(+103.4%) | $37.08 M(+41.9%) |
| Mar 2021 | - | $5.38 M(-74.1%) | $26.13 M(+25.9%) |
| Dec 2020 | $20.75 M | $20.75 M | $20.75 M |
FAQ
- What is Y-mAbs Therapeutics annual revenue?
- What is the all time high annual revenue for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics annual revenue year-on-year change?
- What is Y-mAbs Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics quarterly revenue year-on-year change?
- What is Y-mAbs Therapeutics TTM revenue?
- What is the all time high TTM revenue for Y-mAbs Therapeutics?
- What is Y-mAbs Therapeutics TTM revenue year-on-year change?
What is Y-mAbs Therapeutics annual revenue?
The current annual revenue of YMAB is $84.82 M
What is the all time high annual revenue for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high annual revenue is $84.82 M
What is Y-mAbs Therapeutics annual revenue year-on-year change?
Over the past year, YMAB annual revenue has changed by +$19.55 M (+29.96%)
What is Y-mAbs Therapeutics quarterly revenue?
The current quarterly revenue of YMAB is $18.46 M
What is the all time high quarterly revenue for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high quarterly revenue is $31.45 M
What is Y-mAbs Therapeutics quarterly revenue year-on-year change?
Over the past year, YMAB quarterly revenue has changed by -$1.99 M (-9.74%)
What is Y-mAbs Therapeutics TTM revenue?
The current TTM revenue of YMAB is $84.55 M
What is the all time high TTM revenue for Y-mAbs Therapeutics?
Y-mAbs Therapeutics all-time high TTM revenue is $92.90 M
What is Y-mAbs Therapeutics TTM revenue year-on-year change?
Over the past year, YMAB TTM revenue has changed by -$8.35 M (-8.99%)